(May 13, 2015) -- The stunning testimony of a key witness that the Federal Trade Commission had relied on manufactured evidence to build the agency’s case that LabMD had failed to adequately protect consumers’ confidential data emerged last week as the latest dramatic development in this bitter faceoff. The FTC’s decision not to cross-examine the witness in the administrative trial added yet another surprise....